Skip to content

Nycomed Amersham Imaging

Country not established

Devices
1

What Nycomed Amersham Imaging makes

Nycomed Amersham Imaging produces the Premica CT contrast media delivery system, a device designed for automated administration of contrast agents during computed tomography (CT) scans.

The Premica system is classified as a Class II medical device in the US and is listed under the FDA’s 510(k) pathway. The company is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

Frequently asked questions

How many devices does Nycomed Amersham Imaging have in the registry?

The registry currently lists 1 device for Nycomed Amersham Imaging. Devices recorded under merged duplicate company entries are counted once.

Which registries list Nycomed Amersham Imaging's devices?

Among its 1 most recently registered device, Nycomed Amersham Imaging has devices listed in FDA 510(k) (1 device).

What risk classes do Nycomed Amersham Imaging's devices fall under?

Among its 1 most recently registered device, the classes recorded for Nycomed Amersham Imaging's devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Nycomed Amersham Imaging in the registry?

The most recently registered devices listed for Nycomed Amersham Imaging include PREMICA CT CONTRAST MEDIA DELIVERY SYSTEM.

Generated automatically from registry data and not verified by a human reviewer.